Antiviral agents against influenza viruses

Research output: Contribution to journalReview article

10 Citations (Scopus)

Abstract

In annual epidemics and occasional pandemics, influenza viruses cause acute respiratory illnesses in infected humans. Vaccines and antiviral drugs are two main arsenals available for a fight against influenza viruses. However, vaccines often exhibit a limited efficacy in high risk populations, and antiviral drugs are always concerned for mutations, which confer viral resistance. Here we review current advances and knowledge in relation to the usage of antiviral drugs as a prophylactic or therapeutic and the mechanism of resistant variants mainly against the neuraminidase inhibitors. Comprehensive understanding of the resistant mechanism will pave a road for developing new antivirals and/or finding medical or natural alternatives inducing less frequent resistance, and application of combination therapy using two or three different kinds of antivirals can suggest a useful medical intervention against both of seasonal and highly pathogenic influenza viruses including resistant variants. In this review, we provide insights of antiviral drugs for the control and prevention of influenza viruses.

Original languageEnglish
Pages (from-to)284-293
Number of pages10
JournalJournal of Bacteriology and Virology
Volume42
Issue number4
DOIs
Publication statusPublished - 2012 Jan 1
Externally publishedYes

Keywords

  • Antiviral drugs
  • Combination therapy
  • Influenza
  • Neuraminidase
  • Resistance

ASJC Scopus subject areas

  • Microbiology
  • Immunology
  • Virology

Fingerprint Dive into the research topics of 'Antiviral agents against influenza viruses'. Together they form a unique fingerprint.

  • Cite this